Bill Title: Requires written notice of an adverse determination made by a utilization review agent in relation to a step therapy protocol override determination which includes the clinical review criteria relied upon to make such determination and any applicable alternative prescription drugs subject to the step therapy protocol of the utilization review agent.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Passed) 2024-02-07 - signed chap.28 [A08501 Detail]

Text: Latest bill text (Introduced) [HTML]

---

Voting Records

Chamber	Vote	Date	Yea	Nay	NV	Abs	Total	Result	Source	View
Senate	Senate Floor Vote - Final Passage	2024-01-29	59	0	0	4	63	Passed	Link	View
Assembly	Assembly Floor Vote - Final Passage	2024-01-16	139	2	0	8	149	Passed	Link	View
Assembly	Assembly Insurance Committee: Favorable	2024-01-08	23	0	0	1	24	Passed	Link	View

Social Comments on NY A08501